253 related articles for article (PubMed ID: 23176697)
1. [Acinetobacter baumannii: a rare cause of deep neck infection].
Kınış V; Bakır S; Ozbay M; Yorgancılar E; Topçu I; Tekin A
Kulak Burun Bogaz Ihtis Derg; 2012; 22(6):332-6. PubMed ID: 23176697
[TBL] [Abstract][Full Text] [Related]
2. Deep neck abscess due to Acinetobacter baumannii infection.
Marioni G; Marchese-Ragona R; Boldrin C; Parisi SG; Vianello A; Prencipe RS; Breda C; Staffieri A; Rinaldi R
Am J Otolaryngol; 2010; 31(4):304-7. PubMed ID: 20015765
[TBL] [Abstract][Full Text] [Related]
3. Pan-resistant Acinetobacter baumannii mediastinitis treated successfully with tigecycline: a case report.
Tekçe AY; Erbay A; Çabadak H; Yağcı S; Karabiber N; Şen S
Surg Infect (Larchmt); 2011 Apr; 12(2):141-3. PubMed ID: 21348768
[TBL] [Abstract][Full Text] [Related]
4. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
[TBL] [Abstract][Full Text] [Related]
5. Multidrug-resistant Acinetobacter baumannii infection following para-articular steroid injection in the knee--a case report.
Artiaco S; Cicero G; Bellomo F; Bianchi P
Bull NYU Hosp Jt Dis; 2012; 70(4):276-8. PubMed ID: 23267456
[TBL] [Abstract][Full Text] [Related]
6. Antimicrobial resistance of Acinetobacter baumannii: six years of National Antimicrobial Resistance Surveillance Thailand (NARST) surveillance.
Dejsirilert S; Tiengrim S; Sawanpanyalert P; Aswapokee N; Malathum K
J Med Assoc Thai; 2009 Aug; 92 Suppl 4():S34-45. PubMed ID: 21294501
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of multidrug resistant Acinetobacter baumannii meningitis.
Saçar S; Turgut H; Cenger DH; Coşkun E; Asan A; Kaleli I
J Infect Dev Ctries; 2007 Dec; 1(3):342-4. PubMed ID: 19734617
[TBL] [Abstract][Full Text] [Related]
8. [Antibiotic resistance of Acinetobacter baumannii isolates: data from Ibni Sina Hospital for the year 2002].
Akan OA
Mikrobiyol Bul; 2003 Oct; 37(4):241-6. PubMed ID: 14748260
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Acinetobacter infections.
Michalopoulos A; Falagas ME
Expert Opin Pharmacother; 2010 Apr; 11(5):779-88. PubMed ID: 20210684
[TBL] [Abstract][Full Text] [Related]
10. Acinetobacter baumanii folliculitis in a patient with AIDS.
Bachmeyer C; Landgraf N; Cordier F; Lemaitre P; Blum L
Clin Exp Dermatol; 2005 May; 30(3):256-8. PubMed ID: 15807684
[TBL] [Abstract][Full Text] [Related]
11. Role of combination antibiogram in empirical treatment of infection due to multidrug-resistant Acinetobacter baumannii.
Apisarnthanarak A; Mundy LM
Infect Control Hosp Epidemiol; 2008 Jul; 29(7):678-9. PubMed ID: 18624670
[No Abstract] [Full Text] [Related]
12. Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models.
Yokoyama Y; Matsumoto K; Ikawa K; Watanabe E; Shigemi A; Umezaki Y; Nakamura K; Ueno K; Morikawa N; Takeda Y
Int J Antimicrob Agents; 2014 Jun; 43(6):547-52. PubMed ID: 24796218
[TBL] [Abstract][Full Text] [Related]
13. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections.
Baran G; Erbay A; Bodur H; Ongürü P; Akinci E; Balaban N; Cevik MA
Int J Infect Dis; 2008 Jan; 12(1):16-21. PubMed ID: 17513154
[TBL] [Abstract][Full Text] [Related]
14. Clinical outcomes of patients infected with carbapenem-resistant Acinetobacter baumannii treated with single or combination antibiotic therapy.
Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
J Med Assoc Thai; 2011 Jul; 94(7):863-70. PubMed ID: 21774295
[TBL] [Abstract][Full Text] [Related]
15. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
[TBL] [Abstract][Full Text] [Related]
16. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
Keskin H; Tekeli A; Dolapci İ; Öcal D
Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
[TBL] [Abstract][Full Text] [Related]
17. Drug treatment for multidrug-resistant Acinetobacter baumannii infections.
Bassetti M; Righi E; Esposito S; Petrosillo N; Nicolini L
Future Microbiol; 2008 Dec; 3(6):649-60. PubMed ID: 19072182
[TBL] [Abstract][Full Text] [Related]
18. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
Sayin Kutlu S; Saçar S; Süzer T; Cevahir N; Okke D; Dirgen Caylak S; Turgut H
Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
[TBL] [Abstract][Full Text] [Related]
19. Acinetobacter baumannii and cardiac impairment. Increasingly important nosocomial pathogen.
Tempesta M; Campanella A; Maviglia S
Int J Cardiol; 2015 Oct; 197():164-5. PubMed ID: 26142199
[No Abstract] [Full Text] [Related]
20. Acinetobacter baumannii: an emerging multidrug-resistant threat.
Gootz TD; Marra A
Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
